Ibritumomab Intravenous and Lenvatinib Mesylate
Determining the interaction of Ibritumomab Intravenous and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Lenvima
- Ibritumomab Intravenous-Lenvima (14 MG Daily Dose)
- Ibritumomab Intravenous-Lenvima (18 MG Daily Dose)
- Ibritumomab Intravenous-Lenvima (20 MG Daily Dose)
- Ibritumomab Intravenous-Lenvima (24 MG Daily Dose)
- Ibritumomab Intravenous-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Ibritumomab Tiuxetan
- Lenvatinib Mesylate-Ibrutinib
- Lenvatinib Mesylate-Ibrutinib Capsules
- Lenvatinib Mesylate-Ibrutinib Tablets
- Lenvatinib Mesylate-Ibu
- Lenvatinib Mesylate-IBU Tablets